Literature DB >> 12568206

Comparison of colour duplex ultrasound and ankle-brachial pressure index measurements in peripheral vascular disease in type 2 diabetic patients with foot infections.

G Premalatha1, R Ravikumar, R Sanjay, R Deepa, V Mohan.   

Abstract

BACKGROUND AND OBJECTIVES: Peripheral vascular disease (PVD) is a common cause of morbidity and mortality and is reported to be more common among diabetic subjects compared to non-diabetic subjects. The aim of the study was to compare the specificity and sensitivity of ankle-brachial index (ABI) measured by peripheral doppler with the colour duplex ultrasound (CDU) for diagnosis of PVD.
METHODS: One hundred type 2 diabetic patients admitted to our diabetic centre with foot lesions underwent both colour duplex ultrasound and ankle-brachial index measurements. PVD was diagnosed if the individual had haemodynamically significant obstruction on CDU, or if the ABI was < 0.9. The sensitivity and specificity of ABI was determined using the CDU as 'gold standard'.
RESULTS: The mean age of the study group was 59.5 +/- 10.1 years and the mean duration of diabetes was 11.7 +/- 8.1 years. Of the total 100 subjects, six subjects had calcification of peripheral vessels and they were not included while calculating for sensitivity and specificity of ABI. Twenty (21.3%) subjects diagnosed as PVD by the CDU were not classified as PVD by the ABI measurements. Conversely, only three subjects (3.2%) classified as PVD by ABI had normal arteries based on CDU scanning. Overall, ABI had low sensitivity (70.6%) but a high specificity (88.5%). The overall agreement between CDU and ABI was poor (k = 0.20).
CONCLUSION: ABI is a good initial screening tool but some patients with significant stenosis in lower extremities would be missed, if ABI measurement alone is used for diagnosis of PVD.

Entities:  

Mesh:

Year:  2002        PMID: 12568206

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  13 in total

1.  Symptomatic peripheral arterial disease: the value of a validated questionnaire and a clinical decision rule.

Authors:  Bianca Lw Bendermacher; Joep Aw Teijink; Edith M Willigendael; Marie-Louise Bartelink; Harry R Büller; Ron Jg Peters; Jelis Boiten; Machteld Langenberg; Martin H Prins
Journal:  Br J Gen Pract       Date:  2006-12       Impact factor: 5.386

Review 2.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

3.  Use of a large diabetes electronic medical record system in India: clinical and research applications.

Authors:  Rajendra Pradeepa; Anbalagan Viknesh Prabu; Saravanan Jebarani; Sivasankaran Subhashini; Viswanathan Mohan
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

4.  Comparison of nonenhanced MR angiographic subtraction techniques for infragenual arteries at 1.5 T: a preliminary study.

Authors:  Ruth P Lim; Zhaoyang Fan; Manjil Chatterji; Amanjit Baadh; Iliyana P Atanasova; Pippa Storey; Danny C Kim; Sooah Kim; Philip A Hodnett; Afhsan Ahmad; David R Stoffel; James S Babb; Mark A Adelman; Jian Xu; Debiao Li; Vivian S Lee
Journal:  Radiology       Date:  2013-01-07       Impact factor: 11.105

5.  Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee.

Authors:  Maria Teresa B Abola; Jonathan Golledge; Tetsuro Miyata; Seung-Woon Rha; Bryan P Yan; Timothy C Dy; Marie Simonette V Ganzon; Pankaj Kumar Handa; Salim Harris; Jiang Zhisheng; Ramakrishna Pinjala; Peter Ashley Robless; Hiroyoshi Yokoi; Elaine B Alajar; April Ann Bermudez-Delos Santos; Elmer Jasper B Llanes; Gay Marjorie Obrado-Nabablit; Noemi S Pestaño; Felix Eduardo Punzalan; Bernadette Tumanan-Mendoza
Journal:  J Atheroscler Thromb       Date:  2020-07-04       Impact factor: 4.928

Review 6.  Ankle brachial index for the diagnosis of lower limb peripheral arterial disease.

Authors:  Fay Crawford; Karen Welch; Alina Andras; Francesca M Chappell
Journal:  Cochrane Database Syst Rev       Date:  2016-09-14

7.  Utility of digital pulse oximetry in the screening of lower extremity arterial disease.

Authors:  Jung-Nam Kwon; Whan-Bong Lee
Journal:  J Korean Surg Soc       Date:  2012-01-27

8.  Metabolic syndrome for sub-Saharan Africans diabetes with peripheral arterial disease: a case-control study.

Authors:  Jean Joel R Bigna; Jean Bahebeck; Eugène Sobngwi; Jean Claude Mbanya
Journal:  BMC Res Notes       Date:  2014-02-24

9.  Strain-blood pressure index for evaluation of early changes in elasticity of anterior tibial artery in patients with type 2 diabetes mellitus.

Authors:  Chunpeng Zou; Yan Jiao; Chao Zheng; Yaping Zhao; Xingwang Li
Journal:  Med Sci Monit       Date:  2014-11-24

Review 10.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.